INVENGO
15.2.2017 13:19:25 CET | Business Wire | Press release
Invengo, the global RFID technology provider, today announced the launch of a new generation linen tag, the LinTRAK-Slim, the slimmest UHF RFID tag for the Laundry and Textile Services industry, based on the latest chip available.
Specifically designed to be discreetly integrated into linen and textile products used in commercial laundries and at their customers’ sites such as hospitals and hotels, the LinTRAK-Slim tag is a woven label just 1.2mm thick, making it the thinnest UHF RFID tag on the Textile Services market. Small in size, 10mm wide and 59mm long, the new tag allows for rapid and seamless insertion into the hem of textile items. The tag is based on a unique and patented concept that couples a very small UHF device with a sewed, secondary antenna made from flexible stainless steel thread-like material.
The LinTRAK-Slim integrates Impinj’ Monza® R6-P chip, the latest EPC Gen 2 UHF (RAIN RFID ) chip on the market, designed to drive high-volume applications by combining breakthrough features with unprecedented bulk, stack-reading capacity and speed.
LinTRAK-Slim, which has been tested by world renowned MRI test lab Magnetic Resonance Safety Testing Services , is MRI-compatible and can be used safely in all types of magnetic resonance imaging systems operating at 1.5- and 3-Tesla.
The LinTRAK-Slim completes Invengo’s portfolio of industry-leading RFID tags and stations combined with a linen inventory visibility IoT platform called ACUITY , specifically designed to provide digital analytics and services to the laundry industry and their clients in the Healthcare and Hospitality markets.
"We are particularly excited about this new tag and its innovative features that are the result of fruitful discussions with our customers and end-users throughout the Textile Services Ecosystem, including linen manufacturers, laundry groups, major hotel chains and hospitals," said Richard Bailly , President of Invengo Technologies. "With this slimmer tag, we deliver unique benefits to each layer of the linen value chain, resulting in a groundbreaking product that will fuel market growth."
ABOUT INVENGO
Invengo is a leading developer and manufacturer of high quality, intelligent RFID inlays/tags and connectivity solutions utilized in the Internet of Things.
Invengo Technology Pte.Ltd, located in Singapore, is the international headquarters of Invengo Information Technology Co.Ltd, (SZSE:002161.SZ). Employing 600+ people worldwide, Invengo is one of the largest publicly traded, RFID-oriented companies in the world.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005542/en/
Contact:
Invengo
Angeline Fraud
+33413961127
marketing.tcas@invengo.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights
Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press release
From dating apps to financial details, respondents report seeing a wide range of highly personal information on others' screens 56% of people admit to having looked at strangers’ phone screens accidentally, whereas 24% have done so out of curiosity. 57% identify public transport as the most likely place to notice someone else's screen. While 48%* feel confident they can keep their phone activity private when using it in crowded places, another 52%** acknowledge it is easy to see someone’s screen who is next to you in a public place without trying to look. 33% say they have seen personal content on a stranger’s phone in public. Some smartphone users who have looked at a stranger’s phone screen in public ignore and continue what they were doing (28%) or look away immediately (27%), but others (7%) admit to continuing to look discreetly. The new Samsung Galaxy S26 Privacy Display1 limits side-angle viewing of your screen to protect your privacy in any setting. As millions of Europeans2 ge
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom